EBOLA LIES: SECTION I
- How Ebola is Spread in Humans
- Number of Ebola Cases/Deaths
- Treatments for Ebola
Treatments survivors received
- A Healthy Immune System is Essential to Fighting Any Disease
Tips to a healthier immune system
Ebola was first identified in 1976, in what is now the Democratic Republic of Congo. There were 1,716 confirmed cases of Ebola from 1976 thru 2013. In 2014, there have been more than 16,000 confirmed cases, according to the World Health Organization (WHO), and there may be several times more unreported cases of Ebola. Historically, Ebola has killed as many as 90 percent of those who contract it. The current outbreak has a fatality rate of about 70 percent, probably because of early treatment efforts, officials have said.
Ebola is one of the hemorrhagic fevers of the Filoviridae family of viruses. All types of hemorrhagic fever are characterized by fever and bleeding disorders.
The Ebola incubation period is the period between infection with the virus and the appearance of symptoms associated with the disease. Even if a person exhibits no signs or symptoms of Ebola, he or she can still spread the virus during the incubation period. When a person becomes infected with the Ebola virus, it enters the body and begins to multiply. The virus can travel in the blood to almost any part of the body.
Signs and symptoms of Ebola typically start between two days and three weeks after contracting the virus, although approximately 5 percent of cases may take up to 42 days for symptoms to develop.
The first stage of Ebola is characterized by fever, sore throat, muscle pain, headaches, nausea, vomiting, a rash and diarrhea. The second stage is hemorrhagic fever, in which patients endure difficulty breathing, swallowing, and agonizing bleeding inside their body. Blood pours out of their ears and nose, and turns their eyes from white to red. They die an agonizing death. Generally patients who enter the second stage do not survive.
Ebola virus destroys peoples’ internal organs and the body deteriorates rapidly after death. It softens the tissues and turns them into jelly, even if it is refrigerated to keep it cold. Spontaneous liquefaction is what happens to the body of people killed by the Ebola virus!
According to a doctor treating Ebola patients in Sierra Leone, ‘What shocking is how healthy the patients look before they die and how quickly they decline. A number of the Ebola patients I’ve seen look quite fit and healthy and can be walking around until shortly before their deaths.’
Scientists were always baffled as to how Ebola infected humans. The initial assumption was that it came from humans eating monkeys that had the virus, since there have been Ebola outbreaks in humans and great apes. Then, in 2005, new research led scientists to determine that the virus is carried in three species of fruit bats. The bats show no symptoms of the disease, indicating that they might be spreading it. Experiments have shown that bats survive after being injected with the Ebola virus.
Currently scientists think Ebola is spread by humans eating infected fruit bats, or by humans eating food that has been contaminated by infected fruit bats.
There are at least three deadly strains of Ebola. The Ebola Zaire strain of the virus is believed to be the strain that is currently devastating West Africa. The mortality rate differs between the strains of the virus. The Ebola strains found in Sudan and Uganda kill about a quarter of those who contract it, while the Zaire strain has the highest mortality rate; with as many as 96 percent of infected people dying. The current death rate in West Africa is 70 percent.
If 70 percent of Ebola-infected victims die, that means 30 percent of the victims survive. How do doctors determine an Ebola patient has recovered from the virus and is no longer contagious? According to an infectious disease specialist, when a patient does not show clinical symptoms of the virus for two days, that person is believed to no longer be contagious and lab tests are conducted to make the final determination. The CDC said blood tests are conducted to confirm a patient no longer has Ebola virus circulating in their blood. According to the CDC, contact with a recovered patient, either by their family or members of the public, does not pose a risk. “Individuals who recover from Ebola are not contagious as far as transmitting the virus through close personal contact with blood or body fluids such as urine, feces, sweat, or vomit,” a CDC statement said.
There is some indication that a patient may continue to shed the virus even after a doctor determines the acute infection has subsided. Most likely, the rate at which the virus clears the body varies just as much as the incubation period, which is between 2 and 21 days. According to the WHO, in one instance, a lab worker who contracted Ebola on the job and survived was found to have traces of the virus in his semen 61 days after the initial infection. This could theoretically mean a man could infect his partner during sexual intercourse weeks after he’s declared disease-free.
According to the World Health Organization, “Recent studies conducted in West Africa have demonstrated that 95% of confirmed cases have an incubation period in the range of 1 to 21 days; 98% have an incubation period that falls within the 1 to 42 day interval. WHO is therefore confident that detection of no new cases, with active surveillance in place, throughout this 42-day period means that an Ebola outbreak is indeed over.”
According to reports, “the lead author” of research on Ebola is a Harvard computational biologist that says, “the virus is rapidly accumulating new mutations as it spreads through people.” This means “over 250 … mutations are changing in real time.” The data gathered “also indicate that the outbreak started when just one person caught Ebola from an animal.” Thereafter, the virus spread “through human-to-human transmission–not through humans eating infected bush meat (wild game) as was first thought.”
An expert at Columbia University said he is “not surprised the virus is mutating so rapidly.” Drawing on examples from SARS, HIV, and the flu, he said, “Very often when a new virus is introduced into the human population very suddenly, it will show accelerated rates of evolution.”
HOW EBOLA IS SPREAD IN HUMANS —
There has been much debate about the different ways Ebola can be spread among humans.
Ebola is a hemorrhagic fever, and a fever has always been the most common symptom to look for when someone suspects they may be getting sick with Ebola, but how reliable is a fever as an Ebola symptom?
In 2000 it was reported that the Ebola virus can also infect without producing illness, according to a new finding by African and European scientists. The possibility of asymptomatic infection was only suggested in earlier studies, the scientists said in an issue of The Lancet, a medical journal published in London. However, the scientists had now documented such infections for the first time. They found that the Ebola virus could persist in the blood of asymptomatic infected individuals for two weeks after they were first exposed to an infected individual. How much longer the virus can persist is unknown.
A WHO study of the current outbreak in Liberia, Sierra Leone, and Guinea, involving 3,343 confirmed cases of Ebola, has found that approximately 87% of cases with early Ebola infections had fevers, but 13% did not. In the study, fever was defined as a body temperature of 38 degrees Celsius (100.4 degrees Fahrenheit). During an Ebola outbreak in Uganda in late 2000, researchers discovered that a fever only occurred in 85% of the cases. Another study on 24 confirmed cases of Ebola, found fever in only 88% of cases.
According to a new analysis conducted by an expert in disease transmission, as many as 12 percent of Ebola patients may not show symptoms for more than 21 days after infection, thereby making the current quarantine practices unacceptably short.
Apparently in some cases, Ebola can be present without fever, especially during the first initial phase of infection. The absence of fever is not a reliable indication that an individual is not infected, and the lack of fever should not be used to assess the level of infectiousness of an infected case to others. The concept is not fully supported by published, peer reviewed scientific data.
A study in the prestigious journal Lancet published in 2000 found that some people can carry Ebola without showing any symptoms.
Dr. Beutler, an American medical doctor and researcher, won the Nobel Prize for Medicine and Physiology in 2011 for his work researching the cellular subsystem of the body’s overall immune system – the part of it that defends bodies from infection by other organisms, like Ebola says, “It may not be absolutely true that those without symptoms can’t transmit the disease, because we don’t have the numbers to back that up,” said Beutler, “It could be people develop significant viremia [where viruses enter the bloodstream and gain access to the rest of the body], and become able to transmit the disease before they have a fever, even. People may have said that without symptoms you can’t transmit Ebola. I’m not sure about that being 100 percent true. There’s a lot of variation with viruses.”
One of the target organs for infection by the Ebola virus is the skin, where the virus invades and replicates inside specialized cells called Langahan’s cells.
The presence of the infectious virus in the skin of Ebola patients, and the possibility of transmission through skin shedding was suggested in 1995 during an Ebola outbreak in the Democratic Republic of Congo. At that time, researchers examined the possibility of using skin swabs as a positive alternative diagnostic method for Ebola infection. Testing showed abundant viral proteins and Ebola viral particles in the skin of Ebola patients, reaffirming the role of contact transmission in Ebola.
The timing of when live viral particles appear in the skin has not been well defined during early infection. Epidemiological studies suggest this is not a factor for early case human-to-human transmission, but further studies need to be done.
In 2005, a simple handshake was identified as being able to transmit Ebola. That’s because Ebola can be passed through sweat, and there are sweat glands in hands. Specialists at Emory University Hospital in Atlanta found that the virus is present on a patient’s skin after symptoms develop, underlining how contagious the disease is once symptoms set in.
At a Congressional hearing on October 24, 2014, the Health and Human Services Assistant Secretary was asked about the transmissibility of Ebola. She said Ebola is present in perspiration but did not concede it may be spread on a bus, but did concede that Ebola can live outside the body on inert surfaces. The Major General in charge of troops in the Ebola-infected areas of West Africa said the virus could be spread on a bus or other public transport. This means Ebola can be passed on to others through sweat – and who in a crowded bus has not touched a pole or straphanger where sweat from an ill person may be present?
Ebola is much easier to catch than health officials are admitting, and can be contracted by contact with a doorknob contaminated by a sneeze from an infected person an hour or more before, experts have said. “If you are sniffling and sneezing, you produce microorganisms that can get on stuff in a room. If people touch them, they could be” infected, according to a doctor with the Institute for Public Accuracy in Washington, DC. “The CDC said it doesn’t spread at all by air, then Friday they came out with this poster,” the doctor said. “They admit that these particles or droplets may land on objects such as doorknobs and that Ebola can be transmitted that way.”
A professor of epidemiology at Mercy College, said droplets could remain active for up to a day. “A shorter duration for dry surfaces like a table or doorknob, and longer durations in a moist, damp environment,”according to the professor.
The Ebola virus can survive for two months on cold, moist surfaces. Although the disease typically dies on surfaces within hours, research has discovered it can survive for more than seven weeks under certain conditions.
During tests, the United Kingdom’s Defence Science and Technology Laboratory (DSTL) found that the Zaire strain of Ebola will live on samples stored on glass at low temperatures for as long as 50 days. The tests were done in 2010, but the strain investigated is one of five that is still infecting people globally. For the 2010 study paper, ‘The survival of filoviruses (a category that includes Ebola) in liquids, on solid substrates and in a dynamic aerosol’, the researchers tested two particular filoviruses on a variety of surfaces. These were the Lake Victoria marburgvirus (Marv), and Zebov.
When stored at 4° (39°F), by day 26, viruses from three of the samples were successfully extracted; Zebov on the glass sample, and Marv (which is more deadly than Ebola) on both glass and plastic. By day 50, the only sample from which the virus could be recovered was the Zebov from tissue on glass ‘This study has demonstrated that ﬁloviruses are able to survive and remain infectious, for extended periods when suspended within liquid and dried onto surfaces,’ explained the researchers.
According to the CDC, the virus can survive for a few hours on dry surfaces like doorknobs and countertops and can survive for several days in puddles or other collections of body fluid. However, bleach solutions, including household bleach, can kill the virus on surfaces.
The CDC is not being truthful when they say Ebola typically lives on a dry surface for hours. However, when stored in moist conditions, such as mucus, the life of the virus depends on the surface and room temperature.
You can end up infected with the Ebola virus if you use a bathroom used by an Ebola patient. In general, the disease risk of toilet seats is overrated, but you probably can get Ebola from using a toilet seat after an infectious Ebola patient had recently used it. The risk is not so much the seat itself as the whole bathroom. Always use a toilet seat cover in public restrooms.
In modern buildings, toilets that flush loudly and powerfully are a risk in themselves. The flushing creates a mist of droplets that splash onto the face and hands or may contaminate stall surfaces.
Current epidemiologic evidence indicates that aerosol exposure is not an important means of transmitting Ebola from human-to-human, although infective Ebola virus particles are present in the oral fluid of infected patients, and experimental studies have verified that Ebola infection can be effectively transmitted by oral or conjunctival droplet exposure in monkey and other animal models. Aerosol models of Ebola transmission have been developed in knock-out guinea pigs and monkeys. In addition, mouse-adapted Ebola models of airborne transmission have been developed which show liver damage in all aerosol challenged mice, as well as lung lesions in two of the three strains tested.
While it must be emphasized that airborne droplet and particle transmission between humans has not been evident in epidemiological studies of Ebola outbreaks in Africa, aerosol droplet transmission has been demonstrated in animal models. It is therefore irresponsible for government health officials to emphatically state that aerosol transmission does not occur.
The main criteria for the physiology of airborne transmission of the Ebola virus from animals to humans and from humans to humans exist. These include susceptible cells for infection in the upper human airway, the ability of large aerosol particles to penetrate into the upper airway, and the ability of only a few particles of Ebola virus to initiate an infection. Uncertainty remains in the amount of Ebola virus actually shed by infected humans in their respiratory secretions and the amount of respiratory shedding that occurs during different phases of the disease. This is a factor that may actually vary between the different Ebola strains found in nature. From a biomedical viewpoint, aerosol transmission of the Ebola virus from animals to humans and from humans to humans may be possible under certain conditions. This is significant, as the presence of Ebola virus implies that respiratory, oral, or guano spread of infection could occur in the confined spaces where bats roost. Isolation of the virus from bat feces suggests the existence of mechanism for Ebola transmission to other animals by skin or mucous membrane contact. It should be noted that human Rabies is not considered to be an aerosol transmitted agent, but human Rabies infections have occurred by the inhalation of dried infected bat guano in caves.
Top doctors and virologists are now acknowledging that the Ebola virus has mutated, may have gone airborne, and could kill millions. If certain mutations occurred, it would mean that just breathing would put one at risk of contracting Ebola. Infections could spread quickly to all areas of the globe, as the H1N1 influenza virus did in 2009.
On August 4, 2014, Despite repeated assurances that the Ebola virus cannot be transmitted via airborne particles, the CDC demonstrated its concern about that happening when it directed airline staff to take steps to prevent the spread of “infectious material through the air.” The CDC advisory urged airline staff to provide surgical masks to potential Ebola victims in order “to reduce the number of droplets expelled into the air by talking, sneezing, or coughing.” The CDC also directed airline cleaning personnel to “not use compressed air, which might spread infectious material through the air.”
The CDC’s concern about the Ebola virus being spread via the air is understandable in light of a 2012 experiment conducted by Canadian scientists which proved that, “the Ebola virus could be transmitted by air between species.” Researchers demonstrated that the virus could be transmitted from pigs to monkeys without any direct contact by placing the two animals in pens separated only by a wire barrier. After eight days, some of the monkeys were found to have symptoms of Ebola, likely as a result of “inhaling large aerosol droplets produced from the respiratory tracts of the pigs.”
This wasn’t the first time something like this happened. In 1989, a mutated Ebola virus likely spread through the ventilation system of a Virginia medical lab and infected dozens of monkeys in separate research rooms, highlighting the current potential of an airborne Ebola strain killing millions of people. “Due to the spread of infection to animals in all parts of the quarantine facility, it is likely that Ebola Reston may have been spread by airborne transmission,” according to the book Emerging Infectious Diseases. “On several subsequent occasions during 1989, 1990 and 1996, Ebola Reston killed monkeys in colonies in the United States.”
“Some of the people at the colony in Texas and several of the workers at the facility in the Philippines also produced antibodies to the virus but did not become ill.” The 1989 incident validates concerns that a new, airborne strain of Ebola could infect humans, and if such a mutated strain already exists, it would easily explain why Ebola is currently spreading so rapidly in Africa. For one thing, since Ebola doesn’t replicate itself perfectly every time it infects a victim, each new infection represents a potential mutation of the disease.
A virus researcher that supervised the government’s response to the Ebola outbreak at the Reston facility said that experience confirms his suspicion that the current strain of Ebola afflicting humans might be spread through tiny liquid droplets propelled into the air by coughing or sneezing. “We know for a fact that the virus occurs in sputum and no one has ever done a study [disproving that] coughing or sneezing is a viable means of transmitting,” the researcher said. Unqualified assurances that Ebola is not spread through the air, the researcher said, are “misleading.” Several CDC officials said the primates in Reston had appeared to spread Ebola to other monkeys through their breath.
During a 1995 Ebola outbreak in the Democratic Republic of Congo, the doctor whose CDC team studied cases from 27 infected said that while most cases could be attributed to contact with infected late-stage patients or their bodily fluids, “some” infections may have occurred via “aerosol transmission.”
A spokesman for the CDC, who cited the 1995 study as the most extensive of Ebola’s transmissibility, said that while the evidence “is really overwhelming” that people are most at risk when they touch either those who are sick or such a person’s vomit, blood or diarrhea, “we can never say never” about spread through close-range coughing or sneezing . . . I’m not going to sit here and say that if a person who is highly viremic … were to sneeze or cough right in the face of somebody who wasn’t protected, that we wouldn’t have a transmission,” the spokesman said.
On September 17, 2014, a professor from the School of Public Health, Division of Environmental, and a professor from the Occupational Health Sciences, at the University of Illinois at Chicago, both national experts on infectious disease transmission, reported that Ebola can be transmitted by aerosols (i.e. fluids mixed with air). The professors said, “We believe there is scientific and epidemiologic evidence that Ebola virus has the potential to be transmitted via infectious aerosol particles both near and at a distance from infected patients, which means that healthcare workers should be wearing respirators, not facemasks. [Aerosols are liquids or small particles suspended in air. An example is sea spray: seawater suspended in air bubbles, created by the force of the surf mixing water with air.] The important points are that virus-laden bodily fluids may be aerosolized and inhaled while a person is in proximity to an infectious person and that a wide range of particle sizes can be inhaled and deposited throughout the respiratory tract. Many body fluids, such as vomit, diarrhea, blood, and saliva, are capable of creating inhalable aerosol particles in the immediate vicinity of an infected person. Cough was identified among some cases in a 1995 outbreak in Kikwit, Democratic Republic of the Congo, and coughs are known to emit viruses in respirable particles. The act of vomiting produces an aerosol and has been implicated in airborne transmission of gastrointestinal viruses. Regarding diarrhea, even when contained by toilets, toilet flushing emits a pathogen-laden aerosol that disperses in the air. Zaire Ebola viruses have also been transmitted in the absence of direct contact among pigs and from pigs to non-human primates, which experienced lung involvement in infection. Persons with no known direct contact with Ebola virus disease patients or their bodily fluids have become infected. Experimental studies have demonstrated that it is possible to infect non-human primates and other mammals with filovirus aerosols. [Ebola is a type of filovirus]. Altogether, these epidemiologic and experimental data offer enough evidence to suggest that Ebola and other filoviruses may be opportunistic with respect to aerosol transmission. That is, other routes of entry may be more important and probable, but, given the right conditions, it is possible that transmission could also occur via aerosols.”
In other words, these two infectious disease experts believe that Ebola is already – in its current form – transmissible via aerosols. They therefore urge all doctors and nurses working with Ebola patients to wear respirators.
On October 1, 2014, it was noticed that the Public Health Agency of Canada had deleted information from its official website which indicated that the “airborne spread” of Ebola was strongly suspected by health authorities. Under a section entitled “mode of transmission,” the original text stated that, “airborne spread among humans is strongly suspected, although it has not yet been conclusively demonstrated.” However, the amended text states that, “airborne transmission has not been demonstrated between non-human primates.” Both passages refer to a 2012 study by Canadian scientists which indicated that the Ebola virus could be transmitted by air between different species.
Although there is no confirmation that Ebola has gone airborne, the director of the Center for Infectious Disease Research and Policy at the University of Minnesota, acknowledged in a recent New York Times op-ed that virologists are “loath to discuss openly but are definitely considering in private” the possibility that Ebola has gone airborne.
On October 2, 2014, the United Nations Ebola response chief warned that the longer the Ebola epidemic continues infecting people unabated the higher the chances it will mutate and become airborne.
According to a doctor of biological sciences at Purdue University, “Ebola is primed to have respiratory transmission because it can enter the lung from the airway side.” The doctor has been studying how this particular strain of Zaire/Ebola enters human cells since 2003. He believes that with a few mutations and enough time, it will become airborne.
Numerous scientists say that Ebola can be spread via aerosols created by vomit or the flushing of a toilet with the lid up.
On October 7, 2014, CDC Director Frieden (a CFR) said that the Ebola virus becoming airborne is a possible but unlikely outcome in the current epidemic. “The rate of change [with Ebola] is slower than most viruses, and most viruses don’t change how they spread,” he said. In reality, Ebola mutates each time it comes in contact with a person, and has mutated more than 300 times in the last six months.
Frieden went on to say, “That is not to say it’s impossible that it could change [to become airborne] . . . That would be the worst-case scenario. We would know that by looking at … what is happening in Africa. That is why we have scientists from the CDC on the ground tracking that.” How about the unprecedented number of healthcare workers that are dying from treating Ebola-infected patients?
Also on October 7, 2014, the CDC finally admitted that Ebola can be spread if a carrier coughs or sneezes into the face of a healthcare worker.
On October 8, 2014, it was reported that a group of German medical doctors challenged a key assumption regarding the Ebola virus repeatedly asserted by the director of the CDC in Atlanta, in a peer-reviewed medical journal article that was published Feb. 12, 2009. The researchers found that a patient showing no symptoms of the disease can still transmit a virus like Ebola by air if droplets containing the virus are transmitted to another person by a sneeze or cough.
“A well-known example is poliovirus: over 90% are without infections,” the doctors reported. “During an inapparent infection, sufficient virus replication occurs in the host to induce antiviral antibodies, but not enough to cause disease. Such infections are important for the spread of infection, because they are not easily detected.” The doctors then made the key point that individuals with an inapparent infection, showing no symptoms, can yet spread diseases such as polio. “During the height of the polio epidemic in the United States, the quarantine of paralyzed patients had no effect on the spread of the disease, because 99 percent of the infected individuals had no symptoms and were leading normal lives spreading infection.”
A board-certified family doctor practicing in Maryland said, “We have medical models that say a person is capable of secreting a virus like Ebola in bodily fluids before the person displays symptoms of the disease, and that medical evidence is simply being ignored by Dr. Frieden (a CFR) and the CDC when the public is told repeatedly it’s OK to let Ebola-infected people fly as long as they don’t have a fever.” According to medical literature on virology, asymptomatic but infected individuals can spread a disease to others before showing any signs of being sick.
On October 8, 2014, it was reported that research into past outbreaks shows that the semen of survivors may carry Ebola for weeks, or even months, after they recover. For instance, a 1977 study of an outbreak in what is now the Democratic Republic of Congo found Ebola in the semen of one survivor 61 days after the onset of his disease. A 1999 study found the virus in an Ebola survivor’s semen 82 days after he first became ill. That study recommended that survivors use condoms for “at least” three months after contracting the disease.
In a statement, the WHO confirmed these findings, warning that Ebola “can persist in [survivors’] semen for at least 70 days” and that some research even “suggests persistence for more than 90 days.”
“It can enter the lung from the airway side,” a doctor of biological sciences at Perdue University said on October 13, 2014. “So this argues that Ebola is primed to have respiratory transmission.” The doctor has been studying how this particular strain of Zaire/Ebola enters human cells, since 2003. He believes that with a few mutations and enough time, it will become airborne.
On October 27, 2014, a new CDC flyer describing the “droplet spread” of Ebola was released, which “happens when germs traveling inside droplets that are coughed or sneezed from a sick person enter the eyes, nose, or mouth of another person,” it states. “Droplets travel short distances, less than 3 feet (1 meter) from one person to another. A person might also get infected by touching a surface or object that has germs on it and then touching their mouth or nose,” is nearly identical to the CDC’s description of influenza which states “most experts think that flu viruses are spread mainly by droplets made when people with flu cough, sneeze or talk.” The flyer also said that “Droplet spread diseases include: plague, Ebola.”
This flyer superseded a previous document on Ebola transmission by the CDC, dated October 16, which said nothing about the droplet spread of Ebola, instead claiming that “Ebola is not spread through the air.” It appears the CDC is backtracking from its prior statement and is now slowly admitting that Ebola can spread through coughing and sneezing.
Now the CDC admits that Ebola can travel through the air in aerosols, but claims that it can never go more than 3 feet. Just how accurate is this? The CDC (like the WHO) admits that Ebola can be spread through sneezing or coughing. Yet the CDC itself admits that flu droplets can travel 6 feet. The TV show Mythbusters demonstrated that sneezes can nail people some 17 feet away. However, engineers at MIT show that sneezes can actually travel up to 200 times farther than previously thought … up to 20 feet!
On October 31, 2014, a new document was posted to the Ebola information section of the CDC’s website that stated a person within 6 feet of an Ebola victim may potentially become infected. “A person might also get infected by touching a surface or object that has germs on it and then touching their eyes, mouth or nose,” the document states. “Droplets generally travel shorter distances, less than about 6 feet from a source patient.”
Despite spending the last several months working to convince the public that such transfers were impossible, a CDC advisory from early last August entitled Interim Guidance about Ebola Virus Infection for Airline Flight Crews, Cleaning Personnel, and Cargo Personnel clearly showed that the agency was in fact aware of the potential danger posed by airborne droplets.
A board-certified internist and biological warfare epidemiologist, and an expert in anthrax, argues that the CDC has been lying about aerosol transmission of Ebola, as its own 2009 publication admitted that Ebola: pose[s] a high individual risk of aerosol-transmitted laboratory infections and life-threatening disease that is frequently fatal, for which there are no vaccines or treatments…
Should anyone believe anything the CDC ever says?
Ebola can spread by air in cold, dry weather common to the U.S. but not West Africa, presenting a “possible, serious threat” to the public, according to two studies by U.S. Army scientists. After successfully exposing monkeys to airborne Ebola, which “caused a rapidly fatal disease in 4-5 days,” scientists with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) concluded Ebola can spread through air but likely hasn’t in Equatorial Africa because the region is too warm, with temperatures rarely dropping below 65°F. “Both elevated temperature and relative humidity have been shown to reduce the aerosol stability of viruses.”
In 1995, scientists from the US Army Medical Research Institute of Infectious Diseases (USAMRIID) reported in the International Journal of Experimental Pathology:
We also demonstrated aerosol transmission of Ebola virus at lower temperature and humidity than that normally present in sub-Saharan Africa. Ebola virus sensitivity to the high temperatures and humidity in the thatched, mud, and wattel huts shared by infected family members in southern Sudan and northern Zaire may have been a factor limiting aerosol transmission of Ebola virus in the African epidemics. Both elevated temperature and relative humidity (RH) have been shown to reduce the aerosol stability of viruses (Songer 1967). Our experiments were conducted at 240C [i.e. 75 degrees Fahrenheit] and < 40% RH, conditions which are known to favour the aerosol stability of at least two other African haemorrhagic fever viruses, Rift Valley fever and Lassa (Stephenson et a/. 1984; Anderson et a/. 1991). If the same holds true for filoviruses [Ebola is a type of filovirus], aerosol transmission is a greater threat in modern hospital or laboratory settings than it is in the natural climatic ranges of viruses.
A 2012 study also by the USAMRIID, which exposed monkeys to an airborne filovirus similar to Ebola, reached a similar conclusion to the 1995 study. The study pointed out that filoviruses, which include Ebola and the Sudan virus used in this particular study, have stability in aerosol form comparable to influenza. “Filoviruses in aerosol form are therefore considered a possible, serious threat to the health and safety of the public,” it added.
Also in 2012, scientists from USAMRIID published a report in the journal Viruses finding: Aerosol transmission is thought to be possible and may occur in conditions of lower temperature and humidity which may not have been factors in outbreaks in warmer climates.
The USAMRID study referenced the 1989 Ebola outbreak at a primate quarantine facility in Virginia where the virus rapidly spread between unconnected rooms. This occurred in December, when the temperatures were usually below freezing. The temperature needs to go below 45 degrees to become airborne.
Ebola has been rapidly mutating in 2014. Top doctors say that unless the virus is contained, it could eventually mutate to become airborne. That could make it desirable for terrorists to use Ebola as a bio-weapon. The longer the outbreak rages, the more likely such a scenario becomes.
Once a disease is at the point where every carrier infects 2 more people (exponential spread, which is the current status of the Ebola outbreak), it will continue until it:
A) Runs out of hosts;
B) Is stopped by medical science; or
C) Mutates into something less harmful.
As an example, in the flu pandemic of 1918-1920, 28% of Americans were infected with the disease. Of those 28%, 12% died, which means approximately 625,000 Americans lost their lives, out of some 29,400,000 infections. The population of the United States at that time was 105,000,000 people. If that flu pandemic had hit the United States in 2014, with a population of 317,000,000 people, 88,856,000 people would have been infected and 10,651,000 of them would have died.
Based on information contained in this article, the many ways Ebola can be spread in humans include the following:
1. Touching (including kissing, which is part of the African burial ritual process) the body of a deceased Ebola victim. An Ebola victim is more contagious after they have died than when they were alive, because of all the fluids leaving the body.
2. Touching the skin of an Ebola patient, and also skin shedding by an infected patient.
3. A handshake can transmit Ebola because of the sweat glands in the hands.
4. Touching inert surfaces, such as a bus seat, that has sweat from an Ebola-infected person on it can spread the virus. Household bleach will kill the virus.
5. The Ebola virus can survive outside the body on dry surfaces for several hours, such as a doorknob contaminated by a sneeze from an infected person an hour or more before. Household bleach will kill the virus.
6. You could get Ebola by using a toilet seat an infectious Ebola patient had recently used. Household bleach will kill the virus.
7. The Ebola virus can survive on cold moist surfaces for seven weeks. Household bleach will kill the virus.
8. Coughing or sneezing in the face of someone.
9. Droplets are spread by flushing the toilet with the lid up after an Ebola-infected person has used the toilet.
10. Being nearby when an Ebola-infected person vomits, because of the droplets that may be spread.
11. In previous studies, Ebola has been shown to be airborne between animal species.
12. More and more doctors and scientists are becoming convinced that Ebola can become airborne, and fairly quickly since the virus is mutating.
13. Ebola becomes airborne when the temperature drops below 45 degrees.
14. The Ebola virus remains contagious in semen 90 – 120 days after an Ebola patient has been declared cured of the virus.
15. EBOLA IS CONTAGIOUS WHEN NO SYMPTOMS, INCLUDING FEVER, ARE SHOWING, as was demonstrated in 2000.
NUMBER OF EBOLA CASES/DEATHS —
We constantly hear about how the Ebola death rate is 70%, and cases are rising exponentially, but just how accurate are the statistics the WHO presents?
A major problem for the WHO director and her backers, however, is that her Ebola statistics are very, very dubious. For those whose memory is short, this is the same WHO director that was guilty of trying to panic the world in 2009 into taking unproven vaccines for “Swine Flu” influenza, by declaring a Global Pandemic with statistics calling every case of symptoms, including those of the common cold, to be “Swine Flu,” whether it was runny nose, coughing, sneezing, sore throat. That changed WHO definition of Swine Flu allowed the statistics of the disease to be declared Pandemic. It was an utter fraud, a criminal fraud the director carried out, wittingly or unwittingly (she could be simply stupid but evidence suggests otherwise), on behalf of the major US and EU pharmaceutical cartel.
In a recent article it was admitted that 69 % of all Ebola cases in Liberia registered by WHO have not been laboratory confirmed through blood tests. Liberia is the epicenter of the Ebola alarm in West Africa. More than half of the alleged Ebola deaths, 1,224, as of October 4, 2014, and nearly half of all cases, 2,046, have been in Liberia according to the WHO. The United States FDA diagnostic test used for the lab confirmation of Ebola is so flawed that the FDA has prohibited anyone from claiming they are safe or effective. That means, a significant proportion of the remaining 31 % of the Ebola cases lab confirmed through blood tests could be false cases.
In short, no one knows what 1,224 Liberians in recent weeks have died from, but the WHO claims it was Ebola. Note that the countries affected by the Ebola alarm are among the poorest and most war-torn regions in the world. Wars over blood diamonds and colonial genocidal tribal wars have left a devastated, mal-nourished population in its wake.
In September 2014, the WHO released an official Ebola Fact Sheet that stated, “It can be difficult to distinguish Ebola from other infectious diseases such as malaria, typhoid fever and meningitis.”
Every few years, just like clock work, the Center For Disease Control and Prevention (CDC) and The World Health Organization (WHO) conspire on a new global threat to scare the living daylights out of people. Both these organizations will spread lies of unfathomable magnitude in an attempt to disrupt and instill fear to ultimately exert control and obtain compliance on populations. They’ve done it before with the flu and they’re doing it again with Ebola.
Look no further back than 2009 during the flu pandemic hype, and we have the perfect example of a fabricated international orchestration of deception designed to get billions hooked on the fear bandwagon so that Big Pharma could sell millions of anti-virals and vaccines for a flu that was no more dangerous than the common cold.
Manipulating data, promoting falsehoods, continually misinforming the public and using all forms of media to publicize “a deceptive plan”, are all effective strategies currently deployed to extend a massive psychological operation to world populations.
The orchestrators of pandemics have historically used the same tactics to achieve their goals. Incrementalism plays a large part in priming the populace for vaccination programs so that administering them becomes a voluntary process rather than forced. The incremental approach gradually integrates all demographic and psychographic factors such as age, sex, family size, language, culture, education, job responsibilities, geography, religion, and how every company, product and service could affect response. It is inclusive of all scenarios that could detrimentally affect the operation. By experimenting through the decades, the orchestrators have learned the best psychological tactics through trial and error.
Both the WHO and CDC claim that by employing their monitoring standards on outbreaks from different parts of the world, they are able to obtain sufficient information to make tentative conclusions about how the epidemics may evolve in the coming months. Much of their clever phrasing is convincing enough to conceal the fact that all their disease policies on response and preparation recommendations are based on pure speculation and junk science.
The reporting that Ebola is spreading faster in Africa than efforts to control it is based on substantial misinformation. In particular, in August it was announced that two Americans who had been infected with Ebola were going to be flown back to the US, specifically to Emory University, for treatment, a development that ramped up the fear engine within the media (and the alternative media) about the Ebola virus to even greater heights.
One of the problems is that officials will not collect data on the spread of Ebola based on accurate systematic lab confirmation since they will use unreliable methods such as polymerase chain reaction (PCR). The end point results of conventional PCR are not very precise and end point detection has a very short dynamic range with little chance of detecting the differences between dead or live microorganisms. The CDC is testing all suspected Ebola patients through this method. The PCR method WILL NOT identify if a person is infected with Ebola at contagious levels. Finding trace amounts of Ebola through this method usually means little yet this is how they identify and report to the media that a person is infected.
They will only refer to “confirmed cases” and do not distinguish between confirmed and non-confirmed case. It would appear that the “non-confirmed” cases are categorized as confirmed cases and the numbers are then used by the CDC to prove that the disease is spreading when it isn’t.
Health officials struggling to contain the world’s biggest-ever Ebola outbreak are also struggling with another equally serious problem: bad data. Having accurate numbers about an outbreak is essential not only to provide a realistic picture of the epidemic, but to determine effective control strategies. A WHO official said it’s crucial to track every single Ebola patient in West Africa to stop the outbreak and that serious gaps remain in their data.
“Decisions about prevention and treatment should be data-driven, but we really don’t have the data,” said the director of the National Center for Disaster Preparedness at Columbia University.
A week ago (December 1), the WHO insisted at a media briefing it had mostly met targets to isolate 70 percent of Ebola patients and bury 70 percent of victims safely in Guinea, Liberia and Sierra Leone. But two days later, the WHO backtracked and said that data inconsistencies meant they really didn’t know how many patients were being isolated. Then the WHO also conceded that many of the safe burials were of people not actually killed by Ebola.
“Suddenly you have all these different sources of data that have to be compiled” from different aid agencies, said a data expert at the U.S. CDC. “The ability to actually collect information is a different challenge than responding to the outbreak, and the energy has been focused on the response.” He said local officials are good at tracking known or suspected Ebola cases and their contacts but not as reliable relaying that information to national authorities.
The software built to track Ebola outbreaks was initially designed by the CDC to have one person entering data into a computer. That “was perfectly fine since the dawn of time up until” the outbreak exploded this summer, according to a public health specialist with Doctors Without Borders. The CDC has redesigned the software so now multiple people can enter data, although that created new problems like possible duplication.
These are troubling statistics. First, the WHO says they have almost met their target of isolating 70% of Ebola patients, and safely burying 70% of Ebola victims, which they announced on October 15. Sounds like very encouraging news. Then two days later, the WHO says they don’t know how many patients are being isolated, and how many of the safe burials were actually for Ebola victims.
The WHO puts out weekly contagion reports about the spread of Ebola and the deaths from Ebola, some of which are highlighted below. As you can see, the December 10 report lists recorded deaths at 6,388. This is because on December 1 they said that because of “an error” in numbers in Liberia, the death toll was approximately 6,000, not nearly 7,000 as had been previously reported.
Another interesting thing to note on some of the report highlights below is the apocalyptic death toll projections for the outbreak in West Africa if nothing is done to contain the spread of the virus. So far, the projections haven’t even been close to coming true. That must mean the outbreak is beginning to become contained, as was reported on December 10.
Note that on December 10, the WHO reported, “At a national level, Guinea, Liberia, and Sierra Leone have sufficient capacity to isolate and treat all reported Ebola cases, and bury all Ebola-related deaths safely and with dignity.” How could they have reported one week earlier that they didn’t know how many patients were being isolated or safely buried?
Why would the WHO report success in combating the Ebola outbreak on December 1, announce on December 3 that they have no idea how accurate the information they gave on December 1 was, and then on December 10, give a report similar to the report of December 1? Are these honest mistakes, or did someone realize that if the outbreak ends before the vaccines are ready, big pharma could lose a lot of money?
Highlights of Some of the WHO’s Situation Reports —
3/20/2015 — Recorded cases: 24,753; Recorded deaths: 10,236
On March 20, 2015, the Liberian government confirmed its first new Ebola case in more than a month, which was a setback to the country’s hopes that it would soon be officially declared Ebola free. The WHO had previously announced that no new Ebola case had been registered in Liberia since February 19, 2015. According to unidentified sources, the new case is the wife of a cured Ebola patient. Ebola can live in sperm for more than 90 days after a man has been declared cured of the disease.
Liberia still has the highest Ebola death toll at 4,283, while Sierra Leone has the most confirmed Ebola cases at 11,794.
The first large-scale trial of an Ebola vaccine began in Guinea two weeks ago, after a similar test was started in Liberia. The phase III testing of the vaccine, one of two that are in the most advanced stages of development, aims to ensure it provides protection against the virus.
3/15/2015 — Recorded cases: 24,701; Recorded deaths: 10,194
The WHO reported there were 150 new confirmed cases of Ebola during the week ending March 15, 2015, compared to 116 the previous week. Guinea reported 95 new confirmed cases, its highest weekly total in 2015. Sierra Leone reported 55 new confirmed cases, its lowest weekly total since June 2014. Liberia reported no new confirmed cases for the third consecutive week.
The situation report contains a chart that details the number of confirmed, probable, and suspected cases by cumulative case totals, case totals for the last 21 days, and cumulative death totals for Liberia, Sierra Leone, and Guinea. Liberia did not report the case totals for the last 21 days, or the cumulative death totals. Yet, there is a cumulative death total listed. How can there be a death total listed, when no totals were reported that are used to calculate the cumulative death totals?
3/11/2015 — Recorded cases: 24,350; Recorded deaths: 10,004
On March 11, 2015, the WHO reported that no new cases of Ebola had been registered in Liberia since February 19, 2015, and also mentioned positive signs in Sierra Leone and Guinea. Liberia, long the hardest-hit country in the Ebola epidemic, “has now gone well over two weeks without a new reported case,” a WHO official said. Liberia started its 42-day, or two incubation-period, countdown towards being considered Ebola free on March 4, 2015.
In Sierra Leone, only 58 new confirmed cases were registered last week, the lowest number since last June, although Sierra Leone accounts for the most confirmed Ebola cases with 11,677 as of March 10, 2015. There have been 3,655 Ebola deaths in Sierra Leone, and 3,330 confirmed cases in Guinea with 2,187 deaths.
There have been no new cases reported in the last 10 days in the forest region of Guinea where the outbreak began 15 months ago, a WHO official said. There is “evidence now that Ebola can be stopped . . . this can be done.” The official also said that it should be possible to halt transmission of the virus completely by the middle of the year, but acknowledged that if community resistance continues “it’s a bit of a crapshoot in terms of when transmission will actually stop.”
3/1/2015 — Recorded cases: 23,969; Recorded deaths: 9,807
The WHO’s situation report for the week ending March 1, 2015, shows that Guinea and Sierra Leone reported 132 new confirmed cases of Ebola, an increase of 34 over the previous week. Liberia did not report any new confirmed infections in the week for the first time since May 2014, but the WHO is concerned that disease surveillance may not be optimal given the low number of samples.
The WHO said that only half of the 51 new infections in Guinea came from registered contacts of Ebola patients, and some cases are only identified after post-mortem testing. Sierra Leone recorded 81 new cases, including 26 in the capital Freetown.
Nearly 500 health workers have been among the fatalities.
2/1/2015 — Recorded cases: 22,495; Recorded deaths: 8,981
The WHO reported disappointing news on February 4, 2015. The number of new cases of Ebola rose in all three of West Africa’s worst-hit countries last week, ending several weeks of encouraging declines across the region. The latest figures for the week ending February 1, 2015, showed the first recorded rise in new cases across all three countries this year. Sierra Leone, the worst hotspot, accounted for 80 of the 124 new cases of the disease, Guinea recorded 39, while Liberia had just five, all near the capital Monrovia, the report said.
The WHO said there was an urgent need to step up efforts before the start of the April-May rainy season, when downpours can block roads and make it difficult for health teams to travel.
1/25/2015 — Recorded cases: 22,092; Recorded deaths: 8,810
For the week ending January 25, 2015, there were 99 new confirmed Ebola cases, the lowest tally since June 2014, the WHO said on January 29, 2015, signaling the tide might have turned against the epidemic. “The response to the EVD (Ebola virus disease) epidemic has now moved to a second phase, as the focus shifts from slowing transmission to ending the epidemic,” the WHO said.
The UN Ebola coordinator cautioned that the epidemic was still not totally contained. “The number of cases is decreasing week by week and getting to zero in many places… but we still see occasional flare-ups and we still see some surprises with new cases out of our contact lists,” he said.
Cases and deaths have fallen rapidly in Liberia and Sierra Leone in the past few weeks, with just 20 deaths recorded in Liberia in the 21 days to January 25, 2015. But Guinea reported 30 confirmed cases in the latest week, up from 20 in the previous week. The epidemic is also still spreading geographically there, with a first confirmed case in Guinea’s Mali prefecture bordering Senegal, which just reopened its border with Guinea.
A resurgence of the virus in Guinea, where the outbreak began, would threaten President Alpha Conde’s goal of eradicating Ebola from the country by early March. “Our work is far from over. During the course of this outbreak, we have repeatedly under-estimated this pathogen. We now have a time-limited window of opportunity to eliminate the virus, by April or May the rains will set in in West Africa, limiting our access and our ability to find cases and trace their contacts,” said the Ebola coordinator for UNICEF.
Some 10,000 children have lost one or both parents to the Ebola virus, while five million children have been deprived of education.
The WHO admitted earlier this month that the UN agency had been caught napping on Ebola and pledged reforms to avoid similar mistakes in future.
1/18/2015 — Recorded cases: 21,724; Recorded deaths: 8,641
The Ebola epidemic is slowing significantly in the three west African countries at its epicentre, with fewer than 150 cases reported in the past week, the WHO said on January 21, 2015, adding that those countries were now adequately equipped to stem the tide.
“Case incidence continues to fall in Guinea, Liberia and Sierra Leone,” the WHO said. Liberia, for instance, which had a peak over 300 new cases per week in August and September, only increased by eight new cases last week. Sierra Leone remains hardest-hit, accounting for 117 of the 145 new confirmed cases, against 184 there the previous week and 248 the week before that, the WHO said in its latest update. The WHO also said those countries, which have a creaky health infrastructure and were struggling to deal with the epidemic, were now adequately equipped, largely thanks to international help. They now have “sufficient capacity to isolate and treat patients,” it said.
Every 10 days the number of new cases is halving in Guinea — where, at 20, the figure was the lowest since early August, compared to 45 the week before, the WHO said. In Liberia, where confirmed cases last week fell to eight from a peak of more than 300 per week in August and September, it takes two weeks to halve, and in Sierra Leone nearly 20 days.
The WHO went on to say that each country now also had “sufficient capacity to bury all people known to have died from Ebola.” In addition, the three countries now were able to monitor between 89 and 99 percent of registered contacts on a daily basis, adding that there were 27 laboratories there providing case information services.
Hailing the dramatic fall in the transmission rate, the update said there were only 20 confirmed cases in Guinea last week. The figure for Sierra Leone was 117 last week against 184 a week ago, it said, but added that the rest of the country remained a problem area with the capital Freetown accounting for 30 of last week’s cases.
Mali, which along with Senegal and Nigeria had a minor Ebola scare, was able to declare itself Ebola-free after 42 days without any new cases. Senegal and Nigeria had previously already done so.
12/24/2014 — Recorded cases: 19, 497; Recorded deaths: 7,588
The virus is still spreading intensely in Sierra Leone, especially in the north and west, with 315 new confirmed cases reported in the week to December 21, the WHO said. These included 115 cases in the capital Freetown.
12/14/2014 — Recorded cases: 18,603; Recorded deaths: 6,915
Sierra Leone, neighboring Guinea and Liberia are at the heart of the world’s worst recorded outbreak of Ebola. Rates of infection are rising fastest in Sierra Leone, which now accounts for more than half of the confirmed cases of the virus. The increase in cases in Sierra Leone appeared to have slowed.
12/10/2014 — Recorded cases: 17,942; Recorded deaths: 6,388
The WHO reports that the case incidence is slightly increasing in Guinea, decreasing in Liberia, and may be increasing or stable in Sierra Leone. Sierra Leone now has the highest total number of reported cases of the three intense-transmission countries, with 7,897 cases reported to date. At a national level, Guinea, Liberia, and Sierra Leone have sufficient capacity to isolate and treat all reported Ebola cases, and bury all Ebola-related deaths safely and with dignity. However, local variations mean capacity is still insufficient in some areas. The WHO has officially declared the Ebola outbreak in Spain to be over. That means the U.S. is the only western country with an active Ebola outbreak at the present time.
In an interview,. the WHO director said, “It is not as bad as it was in September, but going forward, we are now hunting the virus, chasing after the virus. Hopefully we can bring [the number of cases] down to zero.”
On October 15, 2014, the WHO assistant director general said that without a strong response, the virus could be infecting as many as 10,000 people a week in West Africa by December 1. Fortunately, that hasn’t been reported to have happened.
12/1/2014 — Recorded cases: 16,899; Recorded deaths: 6,002
The WHO said more than 6,000 people had died from Ebola and not nearly 7,000 as earlier reported, blaming “an error” in numbers out of Liberia. Following the correction, the WHO went with the statistics of November 28, 2014, which stated Guinea had recorded 2,155 cases and 1,312 deaths, Liberia saw 7,635 cases and 3,145 deaths, while Sierra Leone reported 7,109 cases and 1,530 deaths. There have also been 15 fatalities in other countries, bringing the total to 6,002.
On September 4, researchers using computer modeling projected that if the spread of Ebola did not slow down, there could be 100,000 cases by December. In addition, the WHO admitted that the number of cases was likely to grow to 20,000 before too much longer, so global health officials started using apocalyptic language to describe this outbreak. Fortunately their apocalyptic scenarios have failed to materialize, so far.
11/29/2014 — Recorded cases: more than 16,000; Recorded deaths: nearly 7,000
The WHO released their latest infection and death statistics in the Ebola outbreak.
Sierra Leone is now bearing the brunt of the 8-month-old outbreak. In the other hard-hit countries, Liberia and Guinea, WHO says infection rates are stabilizing or declining, but in Sierra Leone, they’re soaring. The country has been reporting around 400 to 500 new cases each week for several weeks.
The bodies of Ebola victims are extremely contagious and the touching of dead bodies might be responsible for as much as 50 percent of all new cases.
11/23/2014 — Recorded cases: 15,935; Recorded deaths: 5,689
Transmission of the virus remains intense in Sierra Leone, especially in the west and north, with the capital Freetown still the worst affected area, the WHO said. Sierra Leone appealed to the United States on November 26, 2014 to send military aid to help it battle Ebola as it falls behind its West African neighbors Guinea and Liberia in the fight against the virus.
“Liberia and Sierra Leone report that fewer than 70 percent of patients are isolated, though there is wide variation among districts,” the WHO said, referring to an international target set for December 1, 2014. However, some data is out of date, it said. Isolation is required to halt further spread of the viral hemorrhagic disease, and the aim is to isolate 100 percent of patients by January 1, 2015, it added.
11/21/2014 — Recorded cases: 15,351; Recorded deaths: 5,459
The update came on the same day the WHO declared the Democratic Republic of Congo free of the disease after the country went 42 days—twice Ebola’s 21-day incubation period—without reporting a new case. The outbreak in the DRC, which is separate from the epidemic in West Africa, killed a total of 49 people.
Ebola’s true overall toll is difficult to gauge because some hard-hit villages are remote and urban centers have showed resistance toward clinics. The WHO has said its count may greatly underestimate the toll and the U.S. Centers for Disease Control and Prevention has said it believes the actual count could be between two and four times the WHO numbers.
11/19/2014 — Recorded cases: 14,413; Recorded deaths: 5,177
The WHO reported a slight rise in the Ebola death toll.
11/15/2014 — Recorded cases: 14,413; Recorded deaths: 5,177
The WHO said the statistics show an increase of 17 deaths since its last update three days ago.
The total of 14,413 cases in eight countries includes 1,187 deaths in Sierra Leone, 1,166 in Guinea and 2,812 in Liberia. The Liberian toll has been revised downwards from 2,836 because of reclassification, the WHO said.
On September 23, the WHO warned the number of Ebola cases could hit 21,000 in six weeks unless efforts to curb the outbreak were ramped up. Fortunately, that hasn’t been reported to have happened.
10/31/2014 — Recorded cases: 13,567; Recorded deaths: 4,951
Ebola has wiped out whole villages in Sierra Leone, according to an official from Doctors without Borders. “The situation is catastrophic. There are several villages and communities that have been basically wiped out. In one of the villages I went to, there were 40 inhabitants and 39 died,” he said. “The WHO says there is a correction factor of 2.5, so maybe it is 2.5 times higher and maybe that is not far from the truth. It could be 10,000, 15,000 or 20,000,” he added.
10/26/2014 — Recorded cases: 10,141; Recorded deaths: 4,922
Mauritania is shutting its borders, as it tries not to become Africa’s 7th Ebola-infected country.
On September 12, a team of researchers projected, “that if the disease continues to spread at the rate it currently is then we will have more than 20,000 cases by October 24. . .” The team believes the number of cases are vastly underreported, so it’s difficult to know if their projection was correct, since some researchers estimate the underreporting rate to be two to four times the reported rate.
10/15/2014 — Recorded cases: 8,997; Recorded deaths: 4,493
According to the WHO assistant director general, the numbers might seem to suggest that half the people stricken with Ebola will survive the disease, but that underestimates the true mortality rate, which is actually 70 percent. Many of the people who have Ebola, and are still fighting it, will yet succumb to the disease.
Without a strong response, the virus could be infecting as many as 10,000 people a week in West Africa by Dec. 1, the assistant director general said.
10/14/2014 — Recorded cases: 8,914; Recorded deaths: 4,447
Global health officials said Tuesday that the death rate in the Ebola epidemic has risen to 70 percent, up from 50 percent.
The WHO made the announcement at a news conference in Geneva, where officials said there could be up to 10,000 new cases of the virus every week within two months.
10/13/2014 — Recorded cases: 8,399; Recorded deaths: 4,033
As of October 8, there are seven Ebola-stricken countries, with Liberia being the worst-hit of all the affected countries, with 4,076 cases and 2,316 deaths. It is followed by Sierra Leone, where there are 2,950 cases and 930 deaths.
Despite all international efforts to combat the disease, the WHO said that Ebola’s spread is “entrenched” and “accelerating.” According to the WHO assistant director general, “The disease is entrenched in the [countries’] capitals, 70 percent of the people affected are definitely dying from this disease, and it is accelerating in almost all of the settings.”
10/9/2014 — Recorded cases: 8,376; Recorded deaths: 4,024
Global health officials are looking closely at the “reproduction number,” which estimates how many people, on average, will catch the virus from each person stricken with Ebola. The epidemic will begin to decline when that number falls below one. A recent analysis estimated the number at 1.5 to 2. The number of Ebola cases in West Africa has been doubling about every three weeks. There is little evidence so far that the epidemic is losing momentum.
“The situation is worse than it was 12 days ago. It’s entrenched in the capitals. Seventy percent of the people [who become infected] are definitely dying from this disease, and it is accelerating in almost all settings,” according to the assistant director general of the World Health Organization.
According to a CDC report produced in late September based on current rates of infection, as many as 1.4 million people would become infected by January. That number, officials stressed, was a straight extrapolation of the explosive spread of Ebola at a time when the world had managed to mount only a feeble response. The more vigorous response underway is designed to bend that curve.
10/8/2014 — Recorded cases: 8,033; Recorded deaths: 3,879
This WHO report of the total number of confirmed, probable, and suspected cases in the West African epidemic of Ebola virus disease (EVD) marks epidemiological week 40 in the outbreak.
10/2/2014 — Recorded cases: 7,470; Recorded deaths: 3,431
The international community has just four weeks to stop the Ebola crisis ‘spiralling completely out of control’, organizations working in West Africa warned today. The number of cases is ‘doubling roughly every three weeks’, the organizations warned. It comes as Save the Children warned five people are infected with the virus every hour.
10/1/2014 — Recorded cases: 7,492; Recorded deaths: 3,439
The overall death toll from the epidemic reached 3,439 out of a total of 7,492 cases in West Africa and the United States as of October 1, the WHO said last week. The U.N. agency’s statistics varied from those compiled by Sierra Leone.
On September 23, the CDC estimated there would be approximately 21,000 total infections, including unreported cases, by September 30 in Liberia and Sierra Leone. According to WHO statistics, there were 6,000 actual and suspected cases. Some estimates of unreported cases are between two and four times what the reported cases are. Unless unreported cases are four times what reported cases are, the CDC estimate was wildly inaccurate.
9/23/2014 — Recorded cases: 5,843; Recorded deaths: 2,803
New estimates from the WHO warn the number of Ebola cases could hit 21,000 in six weeks unless efforts to curb the outbreak are ramped up.
Since the first cases were reported six months ago, there have been an estimated 5,800 cases of Ebola in West Africa. WHO officials say cases are continuing to increase exponentially and Ebola could sicken people for years to come without better control measures.
CDC scientists conclude there may be as many as 21,000 reported and unreported cases in just Liberia and Sierra Leone as soon as the end of this month, according to a draft version of the report obtained by The Associated Press. They also predict that the two countries could have a staggering 550,000 to 1.4 million cases by late January.
An infectious diseases specialist at Doctors Without Borders said, “Ebola outbreaks usually end when people stop touching the sick . . . The outbreak is not going to end tomorrow but there are things we can do to reduce the case count.”
The CDC estimates that in Liberia and Sierra Leone, including unreported cases, there will be about 21,000 total infections by September 30. “Extrapolating trends to January 20, 2015, without additional interventions or changes in community behavior (e.g., notable reductions in unsafe burial practices), the model also estimates that Liberia and Sierra Leone will have approximately 550,000 Ebola cases (1.4 million when corrected for underreporting),” the CDC wrote.
On September 4, a research team, using computer models, projected that the number of Ebola cases would reach 10,000 by September 24th if current trends continued. Fortunately that projection was incorrect.
9/20/2014 — Recorded cases: approximately 2,473; Recorded deaths: more than 1,350
According to the WHO, 106 new deaths were reported over a two-day period, August 17-18, in three countries.
9/12/2014 — Recorded cases: 4,366; Recorded deaths: 2,218
A computer model based on the assumption the WHO and others will be unable to control the Ebola outbreak in West Africa predicts 1.2 million people will die from the disease in the next six months. The WHO projects six months is the minimum time necessary to contain the epidemic.
In developing the model, researchers began with the WHO’s August 28 statement that the Ebola epidemic in West Africa could afflict more than 20,000 people before it is brought under control. “This [estimate of 20,000] assumes full international backing for an intervention to control the deadly outbreak. Failure to support the WHO’s plan presumably would cause the disease to continue to spread in a similar manner as it already has, ” according to the researchers. “At first a figure as high as 20,000 seems exaggerated, especially when looking just at the number of 3,000 cases reported the same day as the announcement. However, we believe that this estimate is vastly too small and is entirely based on an effective and well-funded international relief mission,” the researchers said. Using a projection from all WHO reports through September 5, the researchers calculated, “that if the disease continues to spread at the rate it currently is then we will have more than 20,000 cases by October 24. The report states that it will likely take six to nine months in order to stop the epidemic. However, if nothing changes and the epidemic continues to rage as it currently does, then the projections estimate that as many as 4.7 million people will have been infected and 1.2 million will have already died.” The researchers believe the projections are possible, considering the population of Liberia is over 4 million, with Guinea at 10 million and Sierra Leone at 6 million.
9/9/2014 — Recorded cases: 4,293; Recorded deaths: 2,296
The WHO said it had recorded 4,293 cases in five West African countries as of September 6. It still did not have new figures for Liberia. The outbreak began in Guinea and has spread to Liberia, Sierra Leone, Nigeria and Senegal.
9/9/2014 — Recorded cases: 4,269; Recorded deaths: 2,288
The WHO said that as of September 5, the Ebola death toll in Liberia, Sierra Leone, Guinea and Nigeria was 2,288 out of 4,269 cases, noting nearly half of all infections had occurred in the past 21 days.
The Democratic Republic of Congo is battling a separate outbreak which has killed 32 in a remote northwestern region, according to figures from three days ago.
9/8/2014 — Recorded cases: 3,963; Recorded deaths: 2,104
In Liberia, the disease has killed 1,089 people among 1,871 cases, the highest national toll, according to the WHO. Overall in Guinea, Liberia, Sierra Leone, 2,097 have died out of 3,944 cases. Another 18 cases and seven deaths have been recorded in Nigeria and one non-fatal case in Senegal.
9/5/2014 — Recorded cases: 3,944; Recorded deaths: 2,097
The WHO said the Ebola outbreak has reached across five West Africa countries, with about half the deaths in Liberia.
9/4/2014 — Recorded cases: approximately 3,500; Recorded deaths: more than 1,900
Less than a week ago the death toll stood at 1,552 people. More people have now died in the 2014 Ebola epidemic than in all previous outbreaks combined (1,590, according to the WHO).
The WHO’s director general said that the “Ebola epidemic is the largest, and most severe, and most complex we have ever seen in the nearly 40-year history of this disease.” She added: “No one, even outbreak responders, (has) ever seen anything like it.”
Ebola continues to spread at an exponential rate. According to the WHO, 40 percent of all Ebola cases have happened in just the last three weeks.
One team of researchers has used computer modeling to project that the number of Ebola cases will reach 10,000 by September 24th if current trends continue. If the spread of Ebola does not slow down, we could be dealing with 100,000 cases by December. Even the WHO is admitting that the number of cases is likely to grow to 20,000 before too much longer, and global health officials are now starting to use apocalyptic language to describe this outbreak.
According to the WHO, more than 240 health workers have gotten the virus so far and more than 120 of them have perished. An assistant director-general for the WHO said, “This far outstrips any historic Ebola outbreak in numbers. The largest outbreak in the past was about 400 cases.”
An official WHO statement said, “Staff at the outbreak sites see evidence that the numbers of reported cases and deaths vastly underestimate the magnitude of the outbreak.” According to the international president of Doctors Without Borders: “It is impossible to keep up with the sheer number of infected people pouring into facilities. In Sierra Leone, infectious bodies are rotting in the streets.”
9/2/2014 — Recorded cases: more than 3,000; Recorded deaths: more than 1,500
On September 2, 2014, The WHO said more than 40% of all Ebola cases thus far have occurred in just the last three months, suggesting that the virus is continuing to build steam. A Northeastern University physicist estimates there will be 10,000 cases by September 24th of this year.
Physicist Alessandro Vespignani of Northeastern University in Boston is one of several researchers trying to figure out how far Ebola may spread and how many people around the world could be affected. Based on his findings, it only gets worse from there.
TREATMENTS FOR EBOLA —
The first step in treating any disease is to identify what the disease is, and as quickly as possible so treatment can begin immediately. Current testing methods for identifying Ebola can take eight hours or more to determine if a patient has Ebola, and also produce a disturbing number of false negatives, which means the test has to be taken more than once. The excessive amount of time it takes to accurately identify an Ebola patient can literally mean the difference between life and death.
Experts agreed that a test able to reveal the presence of Ebola on location at an airport checkpoint—and do so in a relatively short amount of time—would greatly improve authorities’ ability to stop the virus from crossing international borders. Corgenix Company received a $3 million National Institutes of Health grant in June to develop a point-of-care test for Ebola. Airport screeners would use it to spot the virus in a feverish passenger in just ten minutes at airports. “Our job is to as quickly as possible advance those tests and make them available in those zones,” the CEO said.
It’s exactly the sort of thing that could provide much more conclusive evidence of a passenger with Ebola. But it won’t be in the hands of airport screeners for years. “We’re several years from getting it completed,” said the CEO. He hopes that Corgenix will have a rapid test for Ebola by 2016.
According to the French developers, a new device similar to a simple pregnancy home-test could allow doctors to diagnose a patient with suspected Ebola in under 15 minutes. Trials at a high-security lab have validated the technique and prototype kits should be available in Ebola-hit countries by the end of October for a clinical trial. “It can give a result in less than 15 minutes for anyone showing symptoms of the disease. Current tests, which are based on genetic detection of the virus, are highly sensitive but need special equipment, take between two and a quarter and two and a half hours and can only be carried out in a lab,” the developers explained in a statement.
This sounds very encouraging, but there’s no mention of what the false negative rate is.
British scientists announced they will be conducting trials on a 15-minute Ebola test in Guinea that they have developed. “A reliable, 15-minute test that can confirm cases of Ebola would be a key tool for effective management of the Ebola outbreak, allowing patients to be identified, isolated and cared for as soon as possible,” said an official of the Wellcome Trust.
Sounds great, but again, there’s no mention of what the false negative rate is.
There is no “official” treatment for Ebola. Patients are usually given palliative care, which means lessening or alleviating their symptoms without curing them. If a victim’s immune system is strong enough to fight off the virus, they will survive. Early detection and basic medical care can improve a patient’s chance of survival. Antibodies to neutralize the virus are also essential to survival. These are obtained from blood transfusions from Ebola survivors.
On September 5, 2014, the WHO said blood transfusions should be the priority for treating Ebola patients. After reviewing the status of all the potential experimental therapies and vaccines being worked on, the WHO felt that treating Ebola patients with blood transfusions from survivors of the disease should be the immediate priority.
The WHO has reported that a black market for an Ebola treatment derived from the blood of survivors is emerging in the West African countries experiencing the worst outbreak of the virus on record. The WHO will work with governments to stamp out the illicit trade in convalescent serum (survivor’s blood), according to the WHO director-general. The WHO is concerned that the serums could contain other infections and wouldn’t be administered properly.
“To survive you have to build up enough antibodies to neutralize the virus. There are no approved drugs to treat Ebola. Patients are given intravenous fluids, blood transfusions and antibiotics to bolster their immune systems and help fight off other infections,” according to the WHO. The blood of survivors has natural antibodies against Ebola. Antibodies are produced by white blood cells and bind to foreign invaders like viruses or bacteria, either neutralizing them or flagging them for destruction by other parts of the immune system. About half of the people infected during the current outbreak have survived, providing a potential pool of donors. The WHO is helping establish a system that can be used to safely draw blood from those who have recovered from the disease, prepare it and re-inject it into patients. Doctors at Emory and Nebraska are also working on lists of survivors by blood type who could donate.
An article appeared in the Journal of Infectious Diseases regarding treating Ebola patients with blood transfusions from survirors blood. The authors of the article concluded that transfusions are probably useful for the treatment or prevention of shock and may provide coagulation factors to stop or to prevent bleeding. But, due to the small number of patients studied and the lack of control subjects, they could not conclude that the neutralizing antibodies in transfused convalescent blood improved the outcome for Ebola patients. However, the results they reported were astounding.
Between January and June of 1995, the Democratic Republic of the Congo (DRC), was the epicenter of an outbreak of Ebola. Ribavirin, an antiviral that is effective in patients with Lassa fever and possibly in patients with Crimean-Congo hemorrhagic fever, had no curative effect in monkeys infected with Ebola.
Following a previous Ebola epidemic, a great effort was made to collect serum from convalescent patients. Convalescent serum, together with human interferon, was given to a British researcher who became infected while working with Ebola virus in the laboratory, and the researcher survived. Whether this was because he received the convalescent serum was unknown.
The treatment of Ebola-infected patients consists mainly of palliative treatment and treatment to avoid cardiovascular collapse and kidney failure. During the initial phase of the Ebola epidemic, very little patient care was offered. The priority was to stop the epidemic and to avoid further spread among health care workers. For this reason, protective equipment was distributed and invasive procedures were avoided. Infusions were rarely given, even if patients were dehydrated. The case fatality rate at that time was approximately 80%. By the last phase of the epidemic, the situation had changed: Health care workers were trained in barrier nursing techniques, there were relatively few patients, and the epidemic was under control. When a nurse from a hospital, who had been caring for Ebola-infected nuns, developed symptoms of Ebola, she was given a transfusion of total blood donated by a convalescent patient. After the transfusion, the patient improved; therefore, seven other patients were treated in a similar manner. All of the eight patients were treated with some form of rehydration solution, numerous other solutions, and some were given Vitamin B, C, or K. All received blood transfusions. Seven of the patients recovered. The eighth patient that died was recovering, but had an epileptic seizure and fell out of bed, hitting her head on the floor. It is unknown if she died from the Ebola, or the head injury.
In June 1995, eight Ebola patients in the Democratic Republic of the Congo were transfused with blood donated by five convalescent patients. The donated blood contained Ebola antibodies but no Ebola antigens. Ebola antigens were detected in all the transfusion recipients just before transfusion. The eight transfused patients had symptoms similar to those of other Ebola patients seen during the epidemic. All were seriously ill with severe weakness, four had hemorrhagic manifestations (bleeding), and two became comatose as their disease progressed. Only one transfused patient (12.5%) died; even though the overall fatality rate for the Ebola epidemic at the time, and the rate for other Ebola epidemics, was 80%.. The reason for this low fatality rate remains to be explained, although the transfused patients did receive better care than those in the initial phase of the epidemic.
Nine Ebola patients have been treated in the U.S. Most were healthcare workers volunteering to treat Ebola patients in West Africa, but two were nurses that contracted Ebola from treating an Ebola patient in a Dallas hospital. Of the nine, eight survived and one died. The treatment protocols two of the patients received are unknown, but of the remaining seven, five received blood transfusions from Ebola survivors. Remember, a blood transfusion from an Ebola survivor can only be given if the donor blood type matches the patient blood type. The Dallas hospital where Thomas Duncan died said they did not have his blood type for use in a transfusion. Six of the seven patients also received an experimental drug, with five of the six surviving. A chart comparing the treatments the patients received can be seen here.
According to a member of the medical team at Emory University Hospital who treated two of the healthcare workers that were given experimental drugs,“It’s hard to derive a lot of meaningful data from the care of just two patients.” Other doctors said they couldn’t tell if the drugs helped. High quality nutrition given intravenously may have helped, as did carefully balanced fluid replacement formulas. Ebola patients often suffer intense vomiting and diarrhea.
In two different 1996 Ebola outbreaks in Africa, there was a 70% death rate. Researchers began wondering why the other 30% survived.
Surprisingly, researchers found many instances where close contacts of those who became infected were never infected at all, even though they were in contact with the infected patient while the patient was symptomatic. The research found that nearly half of those who were asymptomatic and seemingly immune developed antibodies to the Ebola virus. This means when these individuals were exposed to the virus, they naturally developed immunity because their immune systems were strong.
The researchers concluded that, “Asymptomatic individuals had a strong inflammatory response by high circulating concentrations of cytokines and chemokines.” This is the mechanism the body uses to naturally break down and prevent infection from lethal infections including Ebola, HIV, HCV and SARS.
The mechanism is called mannose-binding lectins. Mannose-binding lectins are apparently produced in the human body via a DNA sequence.
When this part of our genes is in order, the body will produce and release these mannose-binding lectins into the bloodstream. Mannose-binding lectins will then recognize and glom onto certain carbohydrate molecules that cover and make up various microorganisms. These microorganisms, including viruses, utilize glycoprotein shells to protect themselves. Once the lectins attach to these shells, they will break apart the surface of the microbe and basically break them down, allowing the body’s other immune cells to kill off the microbe and prevent it from replicating.
Virulent viruses, such as Ebola, Hepatitis C and HIV, come with glycoprotein shells that protect the virus from being broken down. The glycoprotein shell of the Ebola virus produces glycoproteins that damage cells, allowing the virus to penetrate and replicate within the cell. Mannose-binding lectins actually break down this shell and the glycoprotein matrix through a mechanism called the lectin pathway.
Humans that don’t produce enough of these mannose-binding lectins are not only more susceptible because they don’t have enough lectins, but they are typically also immunosuppressed with regard to the rest of their immune system. One of the reason some humans don’t produce enough mannose-binding lectins is because of a slight genetic mutation in the DNA sequence, where the affected gene is switched off. The reason for this mutation/switch-off has yet to be fully understood.
Mannose-binding lectins are not just produced by humans. Red algae also produce these profusely, which allow the algae to protect themselves from invasion by viruses.
In 2003, researchers at the National Cancer Institute isolated a protein extract that was found to bind to HIV-1 viral shells.
Researchers in New Zealand isolated another anti-viral extract from red algae, abbreviated as GRFT, that was successfully tested against HIV-1 and SARS in laboratory studies, some using mice. Multiple studies produced the same effects.
In 2010, Harvard researchers tested a recombinant version of GRFT against Ebola, and once again, they found the mannose-binding lectins not only broke down the viral shells of the Ebola, but when given to Ebola-infected mice, the mice became immune to the virus. Other studies conducted since then have produced similar results.
Apparently the ability of GRFT to treat Ebola was so impressive that the extract from red algae has been patented by the government of the United States, specifically for its ability to treat Ebola, SARS, hepatitis C and H5N1 virus.
On December 1, 2006, the patent was filed and granted – U.S. Patent #US 8088729 B2. The assigned owner of the patent is: “The United States Of America As Represented By The Secretary, Department Of Health And Human Services.”
The “Claims” section of the patent states the following:
“1. A method of inhibiting a viral infection of a host comprising administering to the host an anti-viral polypeptide comprising SEQ ID NO: 3, wherein the viral infection is a Hepatitis C viral infection, a Severe Acute Respiratory Syndrome (SARS) viral infection, an H5N1 viral infection, or an Ebola viral infection, and whereupon the viral infection is inhibited.”
The patent also states:
“An initial observation, which led to the invention, was anti-viral activity of certain extracts from a marine organism, namely Rhodophyte (Griffithsia sp.), originally collected in the territorial waters of New Zealand. Low picomolar concentrations of a protein isolated from the extracts, referred to herein as Griffithsin, irreversibly inactivated human clinical isolates of HIV. Its HIV molecular target is high mannose-comprised oligosaccharide constituents of Env glycoproteins. Upon binding, Griffithsin inhibits viral binding, fusion, and entry. Griffithsin also targets other viruses, such as other retroviruses, e.g., EV, SIV and HTLV, and non-retroviruses, such as measles and, especially, influenza (e.g., H5N1 virus), Ebola, Hepatitis C, and SARS virus.”
Why would the United States Department Of Health And Human Services file a patent on a confirmed treatment for Ebola, HIV, SARS and Hepatitis-C? Does this have anything to do with the patent the government has on some forms of the Ebola virus?
If the federal government owns a cure for these diseases, why are they helping companies work on vaccines that would probably be unnecessary with an Ebola cure? In previous Ebola outbreaks only a few hundred people became infected, whereas with the current outbreak more than 20,000 people have been infected.
According to an orthomolecular physician who administers mega-dose IV vitamin C, he believes that, “… all the hemorrhagic fevers are acute induced scurvy.” Yes, Ebola is a hemorrhagic fever. The level of vitamin C in the blood can be determined with a blood test. That would conclusively prove if the physician’s theory about Ebola being an acute induced scurvy is correct. He doesn’t think the CDC and WHO field workers on location will ever check blood levels of vitamin C among the Ebola-infected West Africans because that would spoil the heroic intervention games that are sponsored by Big Pharma for control and high profits.
During the 1940s and ’50s, a doctor treated many cases of pneumonia and polio with high dose injections of vitamin C. He took his case documents to a 1949 Atlantic City AMA conference and was ignored. He stated, “When proper amounts are used, it will destroy all virus organisms. Don’t expect control of a virus with 100 to 400 mg of C”.
Since then, others began using mega-dose vitamin C therapies for various diseases, physical and mental, with great success. Those doctors formed tight knit communities known as Orthomolecular Medicine and Psychiatry. As for Ebola, they all recommend using high dose vitamin C repeatedly, every hour or two to bowel tolerance limits.
According to WHO officials in Nigeria, those victims who believed that only medicine from the west could save them, mostly died. Those who lived, would not have done so without simple H2O combined with the rehydration solution. “All of them decided to survive. Because they wanted to survive they forced themselves to take more oral rehydration solution. The mind has huge power over the body. That’s not talked about enough.” said an Ebola expert.
You must maintain a strong immune system to be healthy and stay that way. Approximately 70% of your immune system is located in your gut. That is why taking a good quality probiotic is so important. All GMO foods seem designed to destroy your gut, thereby destroying your immune system. The globalists sell products that will make you sick (GMO foods, glyphosate, etc.), then they sell products that make you somewhat better (antibiotics, vaccines, chemotherapy that is actually made from mustard gas, etc.), but they never cure you. Why? There’s no money to be made if you are cured, and nothing is as important to the globalists as money.
Treatments survivors received —
Although there is no approved treatment for Ebola, based on information contained in this article, these are the steps that should be followed as soon as someone is diagnosed with Ebola and admitted to a hospital to give the patient the best chance for survival:
1. Immediately begin giving the patient rehydration solution. Dehydration seems to be a major cause of death.
2. Give them fresh, clean water that does not contain chlorine or fluoride. Feed the patient organic food as much as possible.
3. Administer a properly screened blood transfusion from an Ebola survivor that has the same blood type as the patient.
4. Give massive doses of Vitamin C until the patient develops diarrhea. Then, gradually reduce the dose of Vitamin C until the diarrhea stops, and give that dosage of Vitamin C every two hours.
5. Administer other individualized treatments as necessary for the patient.
A HEALTHY IMMUNE SYSTEM IS ESSENTIAL TO FIGHTING ANY DISEASE —
A newly developed mouse model suggests that genetic factors are behind the severity of reactions to the Ebola virus. Research on Ebola prevention and treatment has been significantly impacted by the lack of a mouse model that replicates the main characteristics of human Ebola hemorrhagic fever.
People exposed to Ebola vary as to what degree the virus affects them. Some are able to completely resist the disease, others suffer moderate to severe illness and recover, but those who are most susceptible succumb to bleeding, organ failure and shock.
In earlier studies of populations of people who have contracted Ebola, these differences are not related to any specific changes in the Ebola virus itself that made it more or less dangerous. Instead, the body’s attempts to fight infection seems to determine disease severity. Which means, the health of your immune system will determine your outcome if you contract Ebola.
Strengthening the body’s immune system will create an effective response to the Ebola virus, and would be one of the best ways to prevent the virus from spreading. Boosting the immune system naturally will give the body its best chance to fight off disease. Some natural therapies for improving the body’s immune system are as follows:
- Estradiol: A 2013 analysis, titled “A systematic screen of FDA-approved drugs for inhibitors of biological threat agents,” found that estradiol, a hormone and steroid produced by women, exhibited anti-Ebola virus activity in vitro, indicating the relevance of hormonal factors and perhaps gender in susceptibility to the disease — as well as a possible therapeutic role for estradiol if future clinical research bears these findings out. “We also identified estradiol and toremifene, two steroidal hormones, as inhibitory to both MARV and EBOV. Interestingly, these compounds have previously been identified as inhibitors of New World arenaviruses but were suggested to interfere with late stages of viral replication and assembly.”Another study reported:
“Anti-EBOV activity was confirmed for both of these SERMs in an in vivo mouse infection model. This anti-EBOV activity occurred even in the absence of detectable estrogen receptor expression, and both SERMs inhibited virus entry after internalization, suggesting that clomiphene and toremifene are not working through classical pathways associated with the estrogen receptor.”
- Garcinia kola: As reported in 1999, extracts from the seeds of this traditional African medicinal herb were found to”…inhibit this virus [Ebola] in cell culture at non-toxic concentrations.”
- Genistein: An organic compound found primarily in soy products, genistein has shown much promise when combined with fellow kinase inhibitor tyrphostin AG1478.A 2011 research paper in the journal Archives of Virology entitled, “Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin,” details the pair’s therapeutic role in reducing the severity of hemorrhagic fever.
“In all, the results demonstrate that a kinase inhibitor cocktail consisting of genistein and tyrphostin AG1478 is a broad-spectrum antiviral that may be used as a therapeutic or prophylactic against arenavirus and filovirus hemorrhagic fever.”
The authors, which include researchers from the University of Texas Medical Branch, also reference a previous animal study which shows genistein’s ability to reduce harm from Pichinde ́virus (PICV), an Ebola-like virus that also causes hemorrhagic fever.
When administered to hamsters, the following results were reported:
“Infection of hamsters with PIRV produces VHF manifestations, including inflammation/lesions in various organs, core temperature increase, weight loss, viremia, petechial rash, hemorrhage, and mortality. Treating the animals with the kinase inhibitor genistein led to a significant increase in survival and to the amelioration of VHF disease signs. None of the treated mock-infected animals had any adverse signs of disease associated with the treatment. Therefore, this study served as a proof-of-concept for using a kinase inhibitor as a therapeutic or prophylactic in an animal model.”
Although genistein and tyrophostin individually inhibited the entry of these viruses into the cells, together they were able to interfere with endocytosis (the process by which a cell pulls in a virus) and uncoating proteins (the process by which a virus alters proteins on the surface of the host cell to gain entry) while also producing a synergistic effect.
“In all, these data demonstrate that infection of host cells with the filoviruses MARV and EBOV and the arenavirus LASV is inhibited when cells are pretreated with genistein or tyrphostin AG1478. In both cases, the inhibition was found to be concentration dependent. Although the inhibition of EBOV in cells pre-treated with 100 lM genistein appeared to differ slightly, the addition of increasing concentrations of tyrphostin AG1478 led to a synergistic antiviral effect. In all, these data demonstrate that a kinase inhibitor cocktail consisting of genistein and tyrphostin AG1478 may act as a broad antiviral against EBOV, MARV, and LASV in vitro.”
Sources of genistein include ferment soy foods, wherein beneficial microbes cause the biotransformation of the precursor phytocompund genistin into genistein, as well as fava beans, kudzu, coffee, and red clover.
- Homeopathic interventions: A study published in 1999 explored the therapeutic potential of a homeopathic preparation of the six-eyed spider venom (Sicarius) at treating symptoms associated with Ebola virus infection.
- Vitamin C: According to the doctor who had extensive experience treating deadly infections with high dose vitamin C, “the Ebola virus kills by way of free radicals which can be neutralized by massive doses of sodium ascorbate intravenously.” He said the symptoms produced by the virus are nearly identical to acute scurvy, a disease that produces bleeding all over the body when levels of vitamin C become depleted. “All of these diseases ultimately kill mostly by free radicals so it does not make any difference as to which disease it is … Since these species (Man, higher monkeys, Guinea pigs and some bats) do not make vitamin C, it is easier for these diseases, by making massive amounts of free radicals which destroy vitamin C, to induce acute systemic scurvy and its resulting high fever, hemorrhaging, etc.,” he said.Vitamin C is well known to have a broad range of benefits, including immune-boosting and antiviral properties, with an incredibly high safety margin. Regular use of vitamin C can boost the immune system to better prepare the body for harmful pathogens.
Tips for a healthier immune system —
1. Eat oranges (organic if possible) for Vitamin C, the white pulp part is very beneficial, rather than drinking the juice, so it won’t affect your blood sugar level as much
2. Raw garlic is a natural antibiotic (Note: use bulb garlic, not elephant garlic which is mild because it is part of the onion family and not a true garlic)
Add chopped fresh raw garlic to Italian salad dressing, or sprinkle chopped fresh raw garlic on pizza just before eating
3. Get at least 7 hours of good sleep at night — your bedroom must be as dark as possible; because if light touches your skin while you are sleeping your body will immediately stop producing serotonin which controls your sleep-wake cycle, among other important functions
4. Reduce your stress
5. Take good quality vitamins — vitamins should be made from whole foods
6. Take good quality probiotics
- Ebola in the United States Timeline — Unavoidable or Premeditated?
- The U. S. Government Response — Total Incompetence or Just Hoodwinking the Public?
According to its website, the CDC is “working 24/7 to protect America from health and safety threats,” and here’s how they do it
- The World Health Organization (WHO), an Agency of the UN, is Trying to Contain and Eradicate the Ebola Outbreak
- How the World is Responding to the Ebola Crisis
How is West Africa coping with the virus?
- Quarantines are Necessary
Examples of why quarantines must be mandatory for at least 21 days, and a person must be housed in a restricted facility, not at home
The potential downside to quarantines is a concern
- The U. S. Army to the Rescue
Are U. S. soldiers being sent to West Africa only to fight Ebola?
- Working Hard on Potential Ebola Treatments
- The Potential Treatments
- What If It Isn’t Ebola?
What is happening to the healthcare workers at an unprecedented rate?
Is this Ebola outbreak actually a bioweapon instead of a viral epidemic?